Q&A: Diversify IBD trials to better understand disease in different populations

Q&A: Diversify IBD trials to better understand disease in different populations

In a commentary published in Gastroenterology, experts propose initiatives that aim to increase diversity in inflammatory bowel disease clinical trials.Nathaniel A. Cohen, MD, advanced IBD fellow at the University of Chicago Medicine Inflammatory Bowel Disease Center, and colleagues identified 641 publications that included 24,315 patients in pivotal IBD trials. There were 32 trials that included race demographics and 10 that included ethnicity demographics. Of these trials, only 12 mentioned the percentage of white participants and 20 reported increased breakdown of race demographics,Read More

Share on facebook
Share on twitter
Share on linkedin